415 related articles for article (PubMed ID: 30385329)
21. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
22. Regulatory effect of nicotine on the differentiation of Th1, Th2 and Th17 lymphocyte subsets in patients with rheumatoid arthritis.
Wu S; Zhou Y; Liu S; Zhang H; Luo H; Zuo X; Li T
Eur J Pharmacol; 2018 Jul; 831():38-45. PubMed ID: 29715455
[TBL] [Abstract][Full Text] [Related]
23. Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses.
Ye Z; Deng B; Wang C; Zhang D; Kijlstra A; Yang P
Sci Rep; 2016 Feb; 6():20401. PubMed ID: 26841832
[TBL] [Abstract][Full Text] [Related]
24. Increased Notch pathway activation in Behçet's disease.
Qi J; Yang Y; Hou S; Qiao Y; Wang Q; Yu H; Zhang Q; Cai T; Kijlstra A; Yang P
Rheumatology (Oxford); 2014 May; 53(5):810-20. PubMed ID: 24446471
[TBL] [Abstract][Full Text] [Related]
25. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
Li B; Xie C; Lin X; Su SB
Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
[TBL] [Abstract][Full Text] [Related]
27. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
[TBL] [Abstract][Full Text] [Related]
28. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
[TBL] [Abstract][Full Text] [Related]
29. Is TGFβ as an anti-inflammatory cytokine required for differentiation of inflammatory T
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
J Immunotoxicol; 2016 Nov; 13(6):775-783. PubMed ID: 27754729
[TBL] [Abstract][Full Text] [Related]
30. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
31. Saliva and Serum Cytokine Profiles During Oral Ulceration in Behçet's Disease.
Novak T; Hamedi M; Bergmeier LA; Fortune F; Hagi-Pavli E
Front Immunol; 2021; 12():724900. PubMed ID: 35003055
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
33. Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis.
Aktas Cetin E; Cosan F; Kucuksezer UC; Bilgic S; Cagatay Y; Gul A; Deniz G
Rheumatol Int; 2013 Mar; 33(3):733-41. PubMed ID: 22576660
[TBL] [Abstract][Full Text] [Related]
34. The imbalance between Tregs, Th17 cells and inflammatory cytokines among renal transplant recipients.
Ma L; Zhang H; Hu K; Lv G; Fu Y; Ayana DA; Zhao P; Jiang Y
BMC Immunol; 2015 Sep; 16():56. PubMed ID: 26400627
[TBL] [Abstract][Full Text] [Related]
35. Tim-3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B.
Wang J; Li C; Fu J; Wang X; Feng X; Pan X
Scand J Immunol; 2019 May; 89(5):e12755. PubMed ID: 30729555
[TBL] [Abstract][Full Text] [Related]
36. Critical role of IL-21 in modulating TH17 and regulatory T cells in Behçet disease.
Geri G; Terrier B; Rosenzwajg M; Wechsler B; Touzot M; Seilhean D; Tran TA; Bodaghi B; Musset L; Soumelis V; Klatzmann D; Cacoub P; Saadoun D
J Allergy Clin Immunol; 2011 Sep; 128(3):655-64. PubMed ID: 21724243
[TBL] [Abstract][Full Text] [Related]
37. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
38. Intracellular cytokine patterns in Behçet's disease in comparison to ankylosing spondylitis--influence of treatment with interferon-alpha2a.
Amberger M; Groll S; Günaydin I; Deuter C; Vonthein R; Kötter I
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S52-7. PubMed ID: 17949552
[TBL] [Abstract][Full Text] [Related]
39. The activation of monocyte and T cell networks in patients with bipolar disorder.
Drexhage RC; Hoogenboezem TH; Versnel MA; Berghout A; Nolen WA; Drexhage HA
Brain Behav Immun; 2011 Aug; 25(6):1206-13. PubMed ID: 21443944
[TBL] [Abstract][Full Text] [Related]
40. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
